Rights and permissions
About this article
Cite this article
Adjunctive IL-3 has no impact on cost of autologous BMT. Pharmacoecon. Outcomes News 159, 8 (1998). https://doi.org/10.1007/BF03295961
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03295961